Cargando…

Adverse drug event patterns experienced by patients with diabetes: A diary study in primary care

PURPOSE: Little is known about adverse drug events (ADEs) experienced over time during chronic drug use. The purpose of this study was to assess ADE patterns experienced by patients with diabetes. METHODS: Patients who received an oral glucose‐lowering drug completed a daily diary for 13 weeks. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Denig, Petra, van Puijenbroek, Eugène P., Soliman, Nashwa, Mol, Peter G. M., de Vries, Sieta T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771843/ https://www.ncbi.nlm.nih.gov/pubmed/31209934 http://dx.doi.org/10.1002/pds.4839

Ejemplares similares

Sex Differences in Adverse Drug Reactions of Metformin: A Longitudinal Survey Study
por: de Vries, Sieta T., et al.
Publicado: (2020)

Sex differences in adverse drug reactions reported to the National Pharmacovigilance Centre in the Netherlands: An explorative observational study
por: de Vries, Sieta T., et al.
Publicado: (2019)

Construct and concurrent validity of a patient-reported adverse drug event questionnaire: a cross-sectional study
por: de Vries, Sieta T, et al.
Publicado: (2014)

Older Age, Polypharmacy, and Low Systolic Blood Pressure Are Associated With More Hypotension-Related Adverse Events in Patients With Type 2 Diabetes Treated With Antihypertensives
por: Ambrož, Martina, et al.
Publicado: (2021)

Patient-Reported Adverse Events of Radiopharmaceuticals: Development and Validation of a Questionnaire
por: Schreuder, Nanno, et al.
Publicado: (2020)

Motives to Report Adverse Drug Reactions to the National Agency: A Survey Study among Healthcare Professionals and Patients in Croatia, The Netherlands, and the UK
por: de Vries, Sieta T., et al.
Publicado: (2021)

Use of a Patient-Friendly Terms List in the Adverse Drug Reaction Report Form: A Database Study
por: de Vries, Sieta T., et al.
Publicado: (2019)

Drug Safety Issues Covered by Lay Media: A Cohort Study of Direct Healthcare Provider Communications Sent between 2001 and 2015 in The Netherlands
por: de Vries, Esther, et al.
Publicado: (2020)

Sex disparities in medication prescribing amongst patients with type 2 diabetes mellitus managed in primary care
por: Ambrož, Martina, et al.
Publicado: (2022)

The Impact of Experiencing Adverse Drug Reactions on the Patient’s Quality of Life: A Retrospective Cross-Sectional Study in the Netherlands
por: Rolfes, Leàn, et al.
Publicado: (2016)

Less Timely Initiation of Glucose-Lowering Medication Among Younger and Male Patients With Diabetes and Similar Initiation of Blood Pressure-Lowering Medication Across Age and Sex: Trends Between 2015 and 2020
por: Ambrož, Martina, et al.
Publicado: (2022)

Trends in HbA(1c) thresholds for initiation of hypoglycemic agents: Impact of changed recommendations for older and frail patients
por: Ambrož, Martina, et al.
Publicado: (2020)

Changes in blood pressure thresholds for initiating antihypertensive medication in patients with diabetes: a repeated cross-sectional study focusing on the impact of age and frailty
por: Ambrož, Martina, et al.
Publicado: (2020)

Interest in a Mobile App for Two-Way Risk Communication: A Survey Study Among European Healthcare Professionals and Patients
por: de Vries, Sieta T., et al.
Publicado: (2018)

The Role of Patients’ Age on Their Preferences for Choosing Additional Blood Pressure-Lowering Drugs: A Discrete Choice Experiment in Patients with Diabetes
por: de Vries, Sieta T., et al.
Publicado: (2015)

Sex Differences in Lipid Profile across the Life Span in Patients with Type 2 Diabetes: A Primary Care-Based Study
por: Ambrož, Martina, et al.
Publicado: (2021)

Diary of Events
Publicado: (2003)

Factors Influencing the Use of a Mobile App for Reporting Adverse Drug Reactions and Receiving Safety Information: A Qualitative Study
por: de Vries, Sieta T., et al.
Publicado: (2016)

Prediction of the Effects of Empagliflozin on Cardiovascular and Kidney Outcomes Based on Short-Term Changes in Multiple Risk Markers
por: Tye, Sok Cin, et al.
Publicado: (2022)

A review of methods used in assessing non-serious adverse drug events in observational studies among type 2 diabetes mellitus patients
por: Hakobyan, Liana, et al.
Publicado: (2011)

Identification of major cardiovascular events in patients with diabetes using primary care data
por: Pouwels, Koen Bernardus, et al.
Publicado: (2016)

Patient preferences and expectation for feedback on adverse drug reaction reports submitted in Ghana
por: Sabblah, George Tsey, et al.
Publicado: (2019)

Factors Influencing Preferences and Responses Towards Drug Safety Communications: A Conjoint Experiment Among Hospital-Based Healthcare Professionals in the Netherlands
por: de Vries, Esther, et al.
Publicado: (2022)

Patient-Reported Adverse Events of Radiopharmaceuticals: A Prospective Study of 1002 Patients
por: Schreuder, Nanno, et al.
Publicado: (2020)

Legislation and current developments in adverse drug reaction reporting in Mongolia: how far are we?
por: Zulzaga, Zuzaan, et al.
Publicado: (2021)

Handling of New Drug Safety Information in the Dutch Hospital Setting: A Mixed Methods Approach
por: de Vries, Esther, et al.
Publicado: (2022)

Safety Communication Tools and Healthcare Professionals’ Awareness of Specific Drug Safety Issues in Europe: A Survey Study
por: de Vries, Sieta T., et al.
Publicado: (2018)

Motives for reporting adverse drug reactions by patient-reporters in the Netherlands
por: van Hunsel, Florence, et al.
Publicado: (2010)

Adverse drug events leading to emergency department visits at an eye hospital: A brief report
por: Alizadeh, Safa, et al.
Publicado: (2017)

Prediction of the Effects of Liraglutide on Kidney and Cardiovascular Outcomes Based on Short-Term Changes in Multiple Risk Markers
por: Tye, Sok Cin, et al.
Publicado: (2022)

A large-scale survey of adverse events experienced in yoga classes
por: Matsushita, Tomoko, et al.
Publicado: (2015)

Characteristics of adverse event reporting of Xeljanz/Xeljanz XR, Olumiant, and Rinvoq to the US Food and Drug Administration
por: Qian, Jingjing, et al.
Publicado: (2022)

Efficacy of Standard and Intensive Statin Treatment for the Secondary Prevention of Cardiovascular and Cerebrovascular Events in Diabetes Patients: A Meta-Analysis
por: de Vries, Folgerdiena M., et al.
Publicado: (2014)

Differences in Importance Attached to Drug Effects Between Patients With Type 2 Diabetes From the Netherlands and Turkey: A Preference Study
por: Roldan Munoz, Sonia, et al.
Publicado: (2021)

Supplementing electronic health records through sample collection and patient diaries: A study set within a primary care research database
por: Joseph, Rebecca M., et al.
Publicado: (2017)

Analysis of Reporting Adverse Drug Reactions in Paediatric Patients in a University Hospital in the Netherlands
por: Dittrich, Anne T. M., et al.
Publicado: (2020)

Quantification of Adverse Drug Reactions Related to Drug Switches in The Netherlands
por: Glerum, Pieter J., et al.
Publicado: (2020)

Evaluating imbalances of adverse events during biosimilar development
por: Vana, Alicia M., et al.
Publicado: (2016)

The Quality of Clinical Information in Adverse Drug Reaction Reports by Patients and Healthcare Professionals: A Retrospective Comparative Analysis
por: Rolfes, Leàn, et al.
Publicado: (2017)

Communication on Safety of Medicines in Europe: Current Practices and General Practitioners’ Awareness and Preferences
por: de Vries, Sieta T., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3d0uaj9bef1nc5uaekimjvbb0u